Related Stories

Insilico Medicine And SK Biopharmaceuticals Achieved AI-powered Drug Discovery Collaboration Worth Up to 2.5 Billion for Neuroimmune Disorders

Insilico Medicine And SK Biopharmaceuticals Achieved AI-powered Drug Discovery Collaboration Worth Up to 2.5 Billion for Neuroimmune Disorders

2026/06/22/13:54:36
Wimbledon and IBM Introduce New AI-Powered Fan Experiences and Modernized Digital Platforms for The Championships 2026 IBM-LOGO-1.jpg?id=OA2727007&p=medium600

Wimbledon and IBM Introduce New AI-Powered Fan Experiences and Modernized Digital Platforms for The Championships 2026

2026/06/22/13:54:36
英矽智能与SK生物制药公司达成25亿美元AI药物研发合作，聚焦神经免疫疾病领域 英矽智能与SK生物制药公司达成25亿美元AI药物研发合作，聚焦神经免疫疾病领域

英矽智能与SK生物制药公司达成25亿美元AI药物研发合作，聚焦神经免疫疾病领域

2026/06/22/13:54:34

You may have missed

Wimbledon and IBM Introduce New AI-Powered Fan Experiences and Modernized Digital Platforms for The Championships 2026 IBM-LOGO-1.jpg?id=OA2727007&p=medium600

Wimbledon and IBM Introduce New AI-Powered Fan Experiences and Modernized Digital Platforms for The Championships 2026

2026/06/22/13:54:36
Insilico Medicine And SK Biopharmaceuticals Achieved AI-powered Drug Discovery Collaboration Worth Up to 2.5 Billion for Neuroimmune Disorders

Insilico Medicine And SK Biopharmaceuticals Achieved AI-powered Drug Discovery Collaboration Worth Up to 2.5 Billion for Neuroimmune Disorders

2026/06/22/13:54:36
英矽智能与SK生物制药公司达成25亿美元AI药物研发合作，聚焦神经免疫疾病领域 英矽智能与SK生物制药公司达成25亿美元AI药物研发合作，聚焦神经免疫疾病领域

英矽智能与SK生物制药公司达成25亿美元AI药物研发合作，聚焦神经免疫疾病领域

2026/06/22/13:54:34
Taylor’s University Ranked Among World’s Top 1% Photo_1.jpg?p=medium600

Taylor’s University Ranked Among World’s Top 1%

2026/06/22/12:53:57
Share via
Facebook
X (Twitter)
LinkedIn
Mix
Email
Print
Copy Link
Copy link
CopyCopied